Search

everythinglearnresearchcommunity

for

Search:↓

Using 5-α-reductase inhibitors before treatment improves outcomes for patients with metastatic renal cell carcinoma.

Further testing of paclitaxel poliglumex for this cancer treatment is not justified.

Exercise-induced particles can slow breast cancer growth by boosting immune response.

Ruxolitinib helped a woman with a genetic mutation regrow her hair and improved her health.

New cancer drugs can cause skin side effects like rashes, dry skin, hair changes, and nail problems.

Cancer prevention has advanced significantly, with some strategies proving successful.

Afatinib often causes skin problems that need proactive management.

Tofacitinib may be safe for COVID-19 patients with alopecia without worsening symptoms, based on two cases.

Upadacitinib improved hair regrowth and quality of life in alopecia areata patients with minimal side effects.

Baricitinib is effective and safe for severe alopecia areata, working similarly with or without an atopic background.

Human placenta helps hair grow back after chemotherapy by blocking cell death and increasing hair follicle growth.

Patients with alopecia areata face challenges accessing Janus kinase inhibitors, but some see positive results.

Laser treatment for skin conditions VEN and ILVEN is effective and liked by patients.

Efalizumab can cause unexpected excessive hair growth.

MK-5108 is safe and shows potential against tumors, especially alone.

The formula YH0618 can reduce the harmful side effects of the chemotherapy drug Doxorubicin and protect healthy cells.

High S100A4 levels worsen glioblastoma by promoting blood vessel growth.

Tofacitinib may help hair regrowth in alopecia areata, but more research is needed.

Blocking CCR5 can prevent and improve hair loss in alopecia areata.

Tofacitinib helped regrow hair in patients with alopecia, with few side effects.

Ixekizumab is effective and safe for patients who did not improve with etanercept treatment for psoriasis.

Tofacitinib effectively treated a woman's complex autoimmune and autoinflammatory disorders.

BOOST is a promising, easy-to-use treatment for diabetic foot ulcers that improves healing by reducing inflammation and promoting blood vessel growth.

PROTAC technology shows promise for cancer treatment but needs more effective E3 ligase recruiters.

Cold caps and certain drugs may help prevent or reduce hair loss from chemotherapy, but more research is needed.

Tofacitinib helped regrow hair in people with severe alopecia, but side effects occurred and benefits stopped after treatment ended.

No treatment fully prevents hair loss from chemotherapy yet.

HSA nanoparticles can improve tamoxifen delivery for breast cancer treatment, reducing side effects.

Valproic acid helps hair follicle stem cells survive better in low oxygen and glucose conditions.

Tofacitinib shows promise for treating severe hair loss in adults and teens, with many experiencing regrowth, but hair loss returns when treatment stops.